摘要
目的探讨早期血压调控在重度子痫前期产妇的临床价值。方法选择我院80例2017年1月-2019年4月重度子痫前期产妇。随机分组,40例对照组患者采取解痉药物治疗,40例观察组患者采取解痉药物联合早期血压调控治疗。比较治疗效果。结果观察组治疗总有效率100%高于对照组75%,χ^2=6.245,P<0.05。观察组血压控制达标时间(5.11±0.45)d短于对照组,t=6.156,P<0.05。观察组母婴并发症发生率(10.00%)低于对照组(37.5%),χ^2=8.352,P<0.05。结论解痉药物联合早期血压调控治疗重度子痫前期可获得较好预后。
Objective To investigate the clinical value of early blood pressure regulation in women with severe preeclampsia.Methods 80 patients with severe preeclampsia admitted to our hospital from January 2017 to April 2019 were enrolled.Randomly,40 patients in the control group were treated with antispasmodic drugs,and 40 patients in the observation group were treated with antispasmodic drugs combined with early blood pressure regulation.The curative effect of the two groups was compared.Results The total effective rate of the observation group was 100%,which was higher than 75%in the control group,χ^2=6.245,P<0.05.The blood pressure control compliance time of the observation group was(5.11±0.45)d,which was shorter than that of the control group,t=6.156,P<0.05.The incidence of maternal and child complications in the observation group was(10.00%),which was lower than that in the control group(37.5%),χ^2=8.352,P<0.05.Conclusion Antispasmodic drugs combined with early blood pressure regulation can achieve better prognosis in severe preeclampsia.
作者
田瑛
TIAN Ying(Department of Obstetrics and Gynecology,Pizhou People's Hospital,Pizhou Jiangsu 221300,China)
出处
《中国卫生标准管理》
2019年第23期71-73,共3页
China Health Standard Management
关键词
重度子痫前期
早期血压调控
疗效
收缩压
舒张压
尿蛋白
severe preeclampsia
early blood pressure regulation
efficacy
systolic blood pressure
diastolic blood pressure
urine protein
